BRD4 and posterior cortical atrophy: While BET inhibitors are already known to target AR-BRD4 interaction to indirectly decrease TMPRSS2-ERG expression through inhibition of the TMPRSS2 promoter [11], this study further demonstrates another mechanism by which BET inhibitors may abrogate PCa progression.